List view / Grid view

Dr Lewis Zhichang Shi

 

news

New research shows way to bypass immunotherapy resistance

A study from the University of Alabama at Birmingham reveals…

3 January 2025 | By

A study from the University of Alabama at Birmingham reveals that HIF1α plays a crucial role in enabling T cells to kill tumour cells under low-oxygen conditions, providing a potential solution to resistance in immune checkpoint blockade (ICB) therapies.